Can tirzepatide or semaglutide cause gallbladder pain?
Yes. Labels for tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) warn of gallbladder disease. In US weight trials, gallstones affected 1.1% on Zepbound and 1.6% on Wegovy injections, against 1% and 0.7% on placebo. Fast weight loss raises the risk but, for Wegovy, doesn't explain all of it. Severe pain under the right ribs needs checking.
How often do gallbladder problems happen?
In trials they affected a small share of people, more than on placebo, and the US Zepbound and Wegovy labels both warn about acute gallbladder disease.12
In two weight trials on the US Zepbound label, gallstones (cholelithiasis) affected 1.1% of people on tirzepatide against 1% on placebo. An inflamed gallbladder (cholecystitis) affected 0.7% against 0.2%, and 0.2% had their gallbladder removed, against none on placebo.1
In adult weight trials on the US Wegovy label, gallstones affected 1.6% on the injection against 0.7% on placebo, and 2.5% on the tablets against 1%. Gallbladder inflammation affected 0.6% on the injection against 0.2%.2 Teenagers had more: 3.8% got gallstones on the injection, against none on placebo.2 The US Ozempic label, from diabetes trials, gives 1.5% on 0.5 mg and 0.4% on 1 mg, with no cases on placebo.3
A 2022 review pooled 76 trials of GLP-1 medicines with 103,371 people. Gallbladder or bile-duct disease was 37% more likely in relative terms, about 27 extra cases per 10,000 people a year. The rise was larger with weight-loss use, higher doses and longer use.11
Is it only because of fast weight loss?
Not entirely. The US Wegovy label says fast or large weight loss raises gallstone risk, but the extra cases remained after allowing for weight lost.2
The same label says gallbladder disease can also happen without substantial or rapid weight loss.2 The US Zepbound label and the EU Mounjaro product information (SmPC) say tirzepatide's gallbladder events were associated with weight reduction.14 Neither tirzepatide label says whether weight loss explains all of them.
What does gallbladder pain feel like?
The NHS describes severe, constant pain in the middle of the tummy or just under the right ribs, lasting from 30 minutes to several hours.12
It may make you feel sick or vomit. The NHS calls this biliary colic, and it happens when a stone blocks a bile duct.12 The US Zepbound and Wegovy labels list upper stomach pain, fever, yellow skin or eyes (jaundice) and pale, clay-coloured stools as gallbladder symptoms.12
Pancreatitis can feel similar. The NHS says its pain starts suddenly, does not go away, can sit between the ribs and may spread to the back. Gallstones are one of its two most common causes, with heavy drinking.13
How is it checked and treated?
Both US labels say a suspected gallbladder problem calls for gallbladder tests and follow-up. The NHS says that usually means an ultrasound scan and a blood test.1212
Most gallstones cause no symptoms and may need no treatment. For stones that do cause symptoms, the main treatment is surgery to remove the gallbladder.12 The US Wegovy label notes that some gallbladder problems need surgery.2 Pancreatitis is usually diagnosed with blood tests and sometimes a CT scan, and it needs urgent hospital treatment.13 Our answer on restarting after gallbladder removal covers what the labels say next.
What do people on GLP-1 medicines report about gallbladder pain?
From public patient forums: 20 Reddit threads in r/Zepbound, r/Mounjaro, r/Ozempic, r/Semaglutide, r/WegovyWeightLoss and r/mounjarouk, read from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Matches the NHS Many describe severe pain in the upper tummy or under the right ribs, sometimes bad enough to seek emergency care. The NHS describes gallstone pain as severe, constant and just under the right ribs.12
- Matches the US Wegovy label Several were later found to have gallbladder disease, and some needed emergency surgery or a hospital stay. The US Wegovy label says some gallbladder problems need surgery.2
- Matches the NHS Several mention pancreatitis, suspected or confirmed in hospital. The NHS names gallstones as one of its most common causes.13
Advice people share
- Label says otherwise Many replies say fast weight loss, not the medicine, causes the stones, though some disagree. The US Wegovy label says the extra gallbladder disease remained after allowing for weight lost.2
- Matches the NHS Many urge seeing a doctor promptly and asking about an ultrasound and blood tests. The NHS lists both as the usual tests.12
- Matches the NHS Many suggest avoiding fried, fatty or large meals. The NHS says people waiting for gallbladder surgery may want to avoid foods that cause symptoms.12
- Emergency guidance says otherwise Several replies describe putting off or leaving medical care despite severe pain. Emergency physicians list any sudden or severe pain as a reason to get emergency care.14
In your country
Every label we could open warns of gallbladder disease. The trial figures and frequency bands differ a little between countries, and three countries' labels were not available to us.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: The Australian Mounjaro Product Information rates acute gallbladder disease, including gallstones, cholecystitis, biliary colic and gallbladder removal, as uncommon (under 1 in 100 people).9 The Australian Wegovy Product Information gives placebo figures of 1.1% for gallstones and 0.3% for cholecystitis, against 1.6% and 0.6% on Wegovy.10
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: The Canadian Zepbound monograph pools three weight trials and gives cholecystitis as 0.6% against 0.2% on placebo.7 The Canadian Wegovy monograph gives the same figures as the US Wegovy label.8
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: The EU Mounjaro SmPC gives cholecystitis as 0.6% against 0.2% on placebo in pooled weight trials, and acute gallbladder disease as 2.0% against 1.6%.4
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: The EU Mounjaro SmPC gives cholecystitis as 0.6% against 0.2% on placebo in pooled weight trials, and acute gallbladder disease as 2.0% against 1.6%.4
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We could not find an Indian label to open, so this page relies on the US labels cited above.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find a Saudi label to open, so this page relies on the US labels cited above.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not find a UAE label to open, so this page relies on the US labels cited above.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro SmPC rates gallstones as common (up to 1 in 10 people) in weight-management trials and uncommon in diabetes trials.5 The UK Wegovy SmPC rates gallstones as common.6
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if you have upper stomach pain, fever, yellow skin or eyes, or pale, clay-coloured stools.12 The NHS advises urgent help for tummy pain lasting longer than 30 minutes. It treats yellow skin or eyes, a very high temperature or shivering, and pain spreading to the back with vomiting as emergencies.12 For severe stomach pain that will not go away, sometimes reaching the back, the US Zepbound label says to stop the medicine and call your healthcare provider right away.1
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information and Medication Guide, Eli Lilly, revised August 2026. Sections 5.4, 5.5 and 17. uspl.lilly.com
- US Wegovy (semaglutide) prescribing information and Medication Guide, Novo Nordisk, revised June 2026. Sections 5.3 and 17. novo-pi.com
- US Ozempic (semaglutide) prescribing information, Novo Nordisk. Section 5.9. novo-pi.com
- EU Mounjaro (tirzepatide) Summary of Product Characteristics, European Medicines Agency. Section 4.8. ema.europa.eu
- UK Mounjaro KwikPen (tirzepatide) Summary of Product Characteristics, emc. Section 4.8. medicines.org.uk
- UK Wegovy FlexTouch (semaglutide) Summary of Product Characteristics, emc. Section 4.8. medicines.org.uk
- Canadian Zepbound (tirzepatide) Product Monograph, Health Canada. pdf.hres.ca
- Canadian Wegovy (semaglutide) Product Monograph, Health Canada. pdf.hres.ca
- Australian Mounjaro (tirzepatide) Product Information, version A14.0, October 2026. medsinfo.com.au
- Australian Wegovy (semaglutide) Product Information. medsinfo.com.au
- He L, et al. Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med 2022;182:513-19. PubMed Central
- NHS. Gallstones. nhs.uk
- NHS. Acute pancreatitis. nhs.uk
- American College of Emergency Physicians. Know When to Go to the ER. emergencyphysicians.org
Last checked Nov 15, 2026 · Next review due Nov 15, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked between Nov 9 and Nov 15, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write